Tumor necrosis factor-alpha antagonists in patients with complicated spinal tuberculosis: A case series and literature review.

Antibiotic exposure Antimicrobial resistance Escherichia coli Fluroquinolones Urinary tract infection

Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
26 Jun 2024
Historique:
received: 13 05 2024
revised: 10 06 2024
accepted: 21 06 2024
medline: 29 6 2024
pubmed: 29 6 2024
entrez: 28 6 2024
Statut: aheadofprint

Résumé

We aimed to quantify the individual risk of antimicrobial resistance among patients with community-acquired Escherichia coli urinary tract infection (UTI) according to their antibiotic exposure over the previous 18 months. French patients were prospectively recruited in two centers in 2015-2017. Resistance of isolates to amoxicillin (AMX), amoxicillin-clavulanate (AMC), third-generation cephalosporins (3GC), trimethoprim-sulfamethoxazole (TMP-SMX), fluoroquinolones (FQ) and fosfomycin (FOS) was analysed according to previous intra-class and inter-class antibiotic exposure documented in health insurance files. Previous antibiotic exposure was found in 588 (81.4 %) of the 722 UTI cases analysed (564 patients). Recent exposure (three months before UTI) was associated with stronger intra-class impact on E. coli resistance compared to remote exposure (18 months before UTI) for AMX, AMC, FQ and TMP-SMX, with respective adjusted odds ratios [95 % confidence interval] of 1.63 [1.20-2.21], 1.59 [1.02-2.48], 3.01 [1.90-4.77], and 2.60 [1.75-3.87]. AMX, FQ, and TMP-SMX also showed significant inter-class impact. Resistance to 3GC was not significantly associated with intraclass exposure (adjusted OR: 0.88 [0.41-1.90]). FOS resistance was remarkably low (0.4 %). Duration of the antibiotic-free period required for resistance risk to drop below 10 %, the threshold for empirical use in UTI, was modelled as < 1 month for 3GC, >18 months for AMX and TMP-SMX and uncertain for AMC (5.2 months [2.3 to > 18]) and FQ (17.4 months [7.4 to > 18]). Resistance of E. coli causing UTI is partially predicted by previous personal antibiotic delivery.

Identifiants

pubmed: 38942293
pii: S2666-9919(24)00108-8
doi: 10.1016/j.idnow.2024.104941
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104941

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Aayesha J Soni (AJ)

Division of Neurology, Department of Medicine, University of Cape Town, Cape Town 7925, South Africa; Neuroscience Institute, University of Cape Town, Cape Town 7925, South Africa.

Yashvir Rugbeer (Y)

Division of Neurology, Department of Medicine, University of Cape Town, Cape Town 7925, South Africa.

Julius Rozmiarek (J)

Department of Radiology, University of Cape Town, Cape Town 7925, South Africa.

Abi Manesh (A)

Department of Infectious Diseases, Christian Medical College, Vellore, Tamil Nadu 632004, India.

Suzaan Marais (S)

Division of Neurology, Department of Medicine, University of Cape Town, Cape Town 7925, South Africa; Neurology Research Group, Neuroscience Institute, University of Cape Town, Cape Town 7925, South Africa. Electronic address: marais.suzaan@gmail.com.

Classifications MeSH